STOCK TITAN

Fulgent Genetics (FLGT) COO reports tax-withholding share disposition after RSU vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Fulgent Genetics, Inc. President and COO Jian Xie reported routine tax-related share withholding tied to equity compensation. On this Form 4, 4,361 shares of common stock were withheld at $16.31 per share to satisfy tax withholding obligations arising from the vesting of restricted stock units assumed in a prior merger.

After this tax-withholding disposition, Xie holds 370,952 common shares directly. In addition, a trust associated with him, The Hsieh Family Dynasty Trust, holds 220,816 shares indirectly; Xie serves on the trust’s investment committee and disclaims beneficial interest except for any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Xie Jian
Role President and COO
Type Security Shares Price Value
Tax Withholding Common Stock 4,361 $16.31 $71K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 370,952 shares (Direct, null); Common Stock — 220,816 shares (Indirect, By Trust)
Footnotes (1)
  1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
Tax-withheld shares 4,361 shares Shares withheld to satisfy tax obligations on RSU vesting
Withholding price $16.31 per share Value used for tax-withholding disposition
Direct holdings after transaction 370,952 shares Common stock directly held by Jian Xie after withholding
Indirect trust holdings 220,816 shares Common stock held by The Hsieh Family Dynasty Trust
restricted stock units financial
"the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting"
Form 4 regulatory
"These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Agreement and Plan of Merger regulatory
"assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
beneficial interest financial
"Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Xie Jian

(Last)(First)(Middle)
C/O FULGENT GENETICS, INC.
4399 SANTA ANITA AVENUE

(Street)
EL MONTE CALIFORNIA 91731

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President and COO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/26/2026F4,361(1)D$16.31370,952D
Common Stock220,816IBy Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.
2. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
/s/ Paul Kim as Attorney-in-Fact04/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Fulgent Genetics (FLGT) President Jian Xie report in this Form 4?

Jian Xie reported a tax-related disposition of shares. 4,361 common shares were withheld at $16.31 per share to cover tax obligations from vested restricted stock units, a non-market transaction tied to his compensation package.

How many Fulgent Genetics (FLGT) shares does Jian Xie hold after this filing?

After the reported transaction, Jian Xie directly holds 370,952 common shares. A separate trust associated with him, The Hsieh Family Dynasty Trust, holds an additional 220,816 shares indirectly, giving context to his overall reported equity exposure.

Was the Jian Xie Form 4 for Fulgent Genetics (FLGT) an open-market sale?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were withheld by the company to satisfy tax obligations triggered when restricted stock units vested, a common administrative step in equity compensation.

What role does The Hsieh Family Dynasty Trust play in Jian Xie’s FLGT holdings?

The Hsieh Family Dynasty Trust holds 220,816 Fulgent Genetics shares indirectly. Jian Xie serves on its investment committee and disclaims beneficial interest except for any pecuniary interest, indicating the trust, not Xie personally, is the formal holder.

What triggered the tax withholding on Jian Xie’s Fulgent Genetics (FLGT) shares?

The withholding was triggered by the vesting of restricted stock units assumed under a prior merger agreement. When these RSUs vested, the company withheld 4,361 shares to cover the resulting tax obligations instead of requiring a separate cash payment.